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ABSTRACT
Objective To evaluate the association between migraine
and cardiovascular disease, including stroke, myocardial
infarction, and death due to cardiovascular disease.
Design Systematic review and meta-analysis.
Data sources Electronic databases (PubMed, Embase,
Cochrane Library) and reference lists of included studies
and reviews published until January 2009.
Selection criteria Case-control and cohort studies
investigating the association between any migraine or
specific migraine subtypes and cardiovascular disease.
Review methods Two investigators independently
assessed eligibility of identified studies in a two step
approach. Disagreements were resolved by consensus.
Studies were grouped according to a priori categories on
migraine and cardiovascular disease.
Data extraction Two investigators extracted data. Pooled
relative risks and 95% confidence intervals were
calculated.
Results Studies were heterogeneous for participant
characteristics and definition of cardiovascular disease.
Nine studies investigated the association between any
migraine and ischaemic stroke (pooled relative risk 1.73,
95% confidence interval 1.31 to 2.29). Additional
analyses indicated a significantly higher risk among
people who had migraine with aura (2.16, 1.53 to 3.03)
compared with people who had migraine without aura
(1.23, 0.90 to 1.69; meta-regression for aura status
P=0.02). Furthermore, results suggested a greater risk
among women (2.08, 1.13 to 3.84) compared with men
(1.37,0.89to2.11).Agelessthan45years,smoking,and
oral contraceptive use further increased the risk. Eight
studies investigated the association between migraine
and myocardial infarction (1.12, 0.95 to 1.32) and five
between migraine and death due to cardiovascular
disease (1.03, 0.79 to 1.34). Only one study investigated
the association between women who had migraine with
aura and myocardial infarction and death due to
cardiovasculardisease,showingatwofoldincreasedrisk.
Conclusion Migraine is associated with a twofold
increasedriskofischaemicstroke,whichisonlyapparent
among people who have migraine with aura. Our results
also suggest a higher risk among women and risk was
furthermagnifiedforpeoplewithmigrainewhowereaged
less than 45, smokers, and women who used oral
contraceptives. We did not find an overall association
between any migraine and myocardial infarction or death
due to cardiovascular disease. Too few studies are
available to reliably evaluate the impact of modifying
factors, such as migraine aura, on these associations.
INTRODUCTION
Migraine is a common, chronic disorder with episodic
attacks.
1 It affects 10-20% of the population during the
mostproductiveperiodsoftheirworkinglives;women
are affected up to four times more often than men.
2
Clinically, migraine is characterised by recurrent
attacks of headache and various combinations of
symptoms related to the gastrointestinal and auto-
nomic nervous system.
3 Up to one third of patients
with migraine experience an aura before or during
the migraine headache characterised by neurological
symptoms most often involving the visual field.
Migraine physiology is incompletely understood.
The condition is viewed as an inherited disorder of
the brain, but vascular mechanisms are clearly impli-
cated. For example, endothelial dysfunction and
hypercoagulability
4 as well as a pathological vascular
reactivity
5areamongtheimportantfindingsinpatients
with migraine. In addition, several population based
and clinic based studies have established a link
betweenmigraineandischaemicstroke.Thisevidence
was summarised in a meta-analysis of data published
until 2004,
6 which found a significant association
between migraine both with and without aura and
ischaemicstroke.Subsequently,threelargecohortstu-
dies,
w1-w3 two case-control studies,
w4 w5 and one cross
sectional study
w6 were published on the association
between migraine and ischaemic stroke, increasing
the available sample from just over 7800 to more than
210000. Results of these new studies suggest that the
association between migraine and ischaemic stroke is
limited to those who have migraine with aura. In addi-
tion, increasing evidence suggests that migraine is also
associated with other ischaemic vascular events,
includingmyocardialinfarctionordeathduetocardio-
vascular disease.
w1-w3 w7-w9 Because of the high preva-
lence of both migraine and cardiovascular disease as
well as the consequences of cardiovascular disease on
morbidity and mortality in the general population, a
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on public health.
We assessed the current evidence on the association
between migraine and cardiovascular disease, includ-
ingstrokesubtypes,myocardialinfarction,angina,and
death due to cardiovascular disease by systematically
reviewingtheliteratureandcarryingouta meta-analy-
sis.Wealso investigatedpotentialmodifying factorsof
the association between migraine and cardiovascular
disease, including migraine aura, sex, age, smoking,
and use of oral contraceptives.
METHODS
We followed the guidelines for the design, perfor-
mance, and reporting for meta-analyses of observa-
tional studies published by the MOOSE group.
7
Two investigators (MS, PMR) independently
searched Medline (from inception to January 2009),
Embase (from inception to January 2009), and the
Cochrane Library (issue 1, 2009) using the terms “head-
ache”or “migraine”or “migraine disorders”in combi-
nation with “cardiovascular diseases” or “stroke” or
“myocardial infarction” or “coronary revasculariza-
tion” or “angina pectoris” or “mortality”. We com-
bined the search terms with the “explode” feature
whereapplicableandappliednolanguagerestrictions.
Inaddition,wemanuallysearchedthereferencelistsof
all primary articles and review articles.
Aprioriwedefinedstrictcriteriaforinclusionofstu-
dies. We chose this approach over a weighting
approach to reduce heterogeneity and to reflect more
accurately the medical reality seen in clinical practice.
Criteria were, firstly, that the studies must have a case-
control or cohort design (we also considered cross sec-
tionalstudiesthatrestrictedtheanalysesoftheassocia-
tion between migraine and cardiovascular disease to
eventsoccurringaftertheonsetofmigraine);secondly,
that the authors must investigate migraine or “prob-
able migraine”; thirdly, that the authors must clearly
define the criteria for the cardiovascular events;
fourthly, that the authors must use a multivariable
model or matching procedure that controls for poten-
tial confounding (if results from more than one multi-
variable model were presented, we used the data from
the model with the maximum control of covariates);
fifthly, that the authors must provide information on
relative risk estimates—that is, odds ratios or hazard
ratios, with 95% confidence intervals; and, finally, if
multiple studies were published from the same study
populationwe only included data from the report with
thelongestfollow-up,orifsimilarwiththelargernum-
berofparticipants,if allstudieshada cohort design,or
we included data from the cohort study instead of the
case-control study, if different designs were used, and
we included subgroup analyses of competing studies if
these data were only provided in one of the studies.
We used two step selection processes to identify eli-
gible studies. In the first step two investigators (MS,
TK) screened the title and abstracts and by consensus
identified all studies that did not meet any of the pre-
specified criteria. We excluded these studies. In the
second step, the same investigators evaluated the full
text versions of the remaining studies. Studies were
excluded if they did not meet all criteria.
Data extraction
Two investigators (MS, PMR) independently extrac-
ted data and entered them in a customised database.
Disagreementswereresolvedbyconsensus.Theextrac-
ted data included authors and title of study, year of
publication, study design, study size, age range and
sex of the participants, smoking status, use of oral con-
traceptives, migraine status (any migraine, migraine
with aura, migraine without aura), investigated out-
come (for example, total stroke, ischaemic stroke,
myocardial infarction, angina), and relative risks with
95% confidence intervals for each of the associations
investigated. All data were extracted from the pub-
lished studies and we did not contact the authors for
further information.
Statistical analysis
For our analyses we grouped the studies according to
thenumberavailable.Weusedtheoutcomecategories
as presented in the original articles (box). For the cate-
gory of any migraine and ischaemic stroke, we
included only studies that looked at any migraine (we
did not pool results from migraine with and without
aura) and that used strict criteria for ischaemic stroke
(studies showing only combined results for ischaemic
stroke and transient ischaemic attacks were excluded).
We included studies irrespective of sex and age distri-
bution. In addition to the overall analysis, we carried
out stratified analyses according to study type (case-
control v cohort), sex, age (<45 years v ≥45 years), use
of oral contraceptives (current v none), and smoking
status (current v not current). For the category of
migraine with aura and ischaemic stroke we also
looked at the subgroups of smokers, women currently
using oral contraceptives, and women currently using
oral contraceptives and smoking. For the analyses
including any migraine and either myocardial infarc-
tion, angina,or deathduetocardiovascular diseasewe
lookedatresultsforoverallmigraineamongallstudies
as well as analyses stratified by sex, and results for
migraine with and without aura separately.
Categories of studies included in systematic review and meta-analysis
Any migraine and ischaemic stroke
Migraine with aura and ischaemic stroke
Migraine without aura and ischaemic stroke
Any migraine and transient ischaemic attack
Any migraine and haemorrhagic stroke
Any migraine and any stroke
Any migraine and myocardial infarction
Any migraine and angina
Any migraine and death due to cardiovascular disease
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case-control studies approximate the hazard ratios
fromcohortstudies.Toobtainpooledrelativeriskesti-
mates we weighted the log of the odds ratios or hazard
ratios by the inverse of their variance. We ran random
effectsmodels,whichincludeassumptionsonpotential
variability across studies. We used the DerSimonian
and Laird Q test for heterogeneity. Since this test sta-
tistic has low power with studies of small sample size
and excessive power if there are many studies (espe-
ciallyiftheyarelarge),wealsocalculatedtheI
2statistic
for each analysis.
8 This statistic describes the percen-
tage of total variation across studies that is due to het-
erogeneityratherthanchance(25%lowheterogeneity,
50% medium, 75% high). We used Galbraith plots
9 to
visually examine the impact of individual studies on
the overall homogeneity test statistic, and we used
meta-regressiontoevaluatetheamountofheterogene-
ityofstudytype,sex,andmigraineaurastatusonsome
of the cardiovascular events. We evaluated potential
publication bias by visually examining for possible
skewness in funnel plots
10 and statistically with the
methods described by Begg and Mazumdar
10 and
Egger.
11 Egger’s method uses a weighted regression
approach to investigate the association between out-
come effects (log odds ratio or log hazard ratio) and
its standard error in each study. Analyses were carried
out with Stata 8.2.
RESULTS
Figure 1 summarises the selection of studies. Of 5746
potentially eligible articles identified through the elec-
tronic search, 5714 were excluded after an evaluation
ofthetitleandabstract.Afurthersevenwereexcluded:
two used the same cohorts as other studies but had
shorter follow-up,
1213 one did not present confidence
intervalsfortherelativerisks,
14onewascrosssectional
and did not present overall estimates for the follow-up
data,
15 one was cross sectional and the temporal asso-
ciation between migraine and cardiovascular events
was not clear,
16 one used only descriptive statistics,
17
and one was a case-control study from a database that
also contained a cohort analysis.
18 Overall, 25 studies
were suitable for inclusion in the analysis (table 1).
Study characteristics
Thirteen of the 25 studies were case-control studies,
w4
w5 w10 w12-w16 w20 w22-w25 10 cohort studies,
w1-w3 w7-w9 w11 w17-
w19and twocrosssectionalstudies.
w6 w21Both crosssec-
tional studies presented results for cardiovascular
events after the diagnosis of migraine.
Eighteenstudiespresentedresultsforanymigraine
w1-
w3 w7-w13 w15 w16 w18 w19 w22-w25 and 16 for migraine with and
without aura separately.
w3-w6 w11-w14 w16-w21 w24 w25
The cardiovascular events investigated were hetero-
geneous. Three studies looked at the association of
migraine with major cardiovascular disease,
w2 w3 w17
16 with ischaemic stroke,
w1-w6 w12-w18 w23-w25 three with
transient ischaemic attacks,
w8 w11 w12 three with com-
bined ischaemic stroke and transient ischaemic
attacks,
w10 w20 w22 five with haemorrhagic stroke,
w1 w10
w13 w18 w23 five with any stroke,
w1 w8 w11 w13 w18 six with
myocardial infarction,
w1-w3 w7 w8 w17 five with angina,
w2
w3 w8 w9 w21 three with coronary revascularisation proce-
dures,
w2 w3 w9 one with death due to coronary heart dis-
ease,
w19 and five with death due to cardiovascular
disease.
w1-w3 w8 w9
Tenstudiespresentedresultsforwomenonly,
w3 w4 w9
w10 w13 w14 w17 w18 w23 w25 one for men only,
w2 seven for
overallmixedcohortsofmenandwomenwithoutstra-
tification by sex,
w1 w5 w6 w8 w16 w20 w22 three for overall
cohorts plus stratification by sex,
w11 w12 w24 and four
only for women and men separately.
w7 w15 w19 w21
The age in the studies ranged from 15 to 80 years.
Elevenpresentedresultsforparticipantsagedlessthan
45
w5 w7 w10-w14 w20 w23-w25 and eight for those aged 45 or
more.
w3 w6 w7 w11 w17-w19 w21 Five studies presented results
stratified by smoking,
w4 w13 w17 w24 w25 four stratified
results for women according to oral contraceptive
use,
w4 w10 w13 w25 and one only included women using
oral contraceptives.
w23
Table 2 summarises the association between
migraine and stroke in the included studies. Table 3
summarises the association between migraine and
myocardialinfarction,angina,anddeathduetocardio-
vascular disease. Table 4 shows the results from the
pooled analyses, including measures of heterogeneity
and publication bias.
Association between migraine and stroke
Nine studies investigated the association between any
migraine and ischaemic stroke, which fulfilled the
inclusion criteria.
w1-w3 w12 w13 w15 w16 w24 w25 The pooled
relative risks were 1.73 (95% confidence interval 1.31
to 2.29) for all studies (fig 2), 1.96 (1.39 to 2.76) for the
six case-control studies,
w12 w13 w15 w16 w24 w25 and 1.47
(0.95 to 2.27) for the three cohort studies.
w1-w3
Articles identified from electronic search (n=5746):
  PubMed (n=2095)
  Embase (n=3395)
  Cochrane Library (n=256)
Potentially eligible articles on basis of title and abstract (n=32)
Articles included (n=25)
Articles excluded after evaluation of title and abstract
  (n=5714):
    Redundant articles
    Outcomes not relevant
    Reviews and editorials
    Case reports
Excluded (n=7):
  Studies used same cohort as others but had shorter
    follow-up (n=2)
  Cross sectional (n=1)
  Cross sectional and did not present overall effect
    estimates for follow-up data (n=1)
  Used only descriptive statistics (no control for
    confounding, no relative risk) (n=1)
  Did not present confidence intervals for relative risk (n=1)
  Case-control study from database, where also cohort
    analysis was available (n=1)
Fig 1 | Process of study selection
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Study design, reference (country) Study size
Population
(age at study entry) Migraine type
Cardiovascular disease
events investigated Comment
Case-control:
Collaborative Group 1975 (USA)
w10 430 cases,
429 hospital controls
or 451 neighbour controls
Women (15-44) Any Ischaemic stroke+transient ischaemic
attack, haemorrhagic stroke
Only stratified analysis according to oral
contraceptive use
Henrich 1989 (USA)
w16 89 cases, 178 controls Both sexes (15-65) Any, migraine with
and without aura
Ischaemic stroke
Marini 1993 (Italy)
w20 308 cases, 616 controls Both sexes (15-44) Migraine with
and without aura
Ischaemic stroke+transient ischaemic
attack
Tzourio 1993 (France)
w24 212 cases, 212 controls Both sexes, women,
men (18-80)
Any, migraine with
and without aura
Ischaemic stroke
Tzourio 1995 (France)
w25 72 cases, 173 controls Women (18-44) Any, migraine with
and without aura
Ischaemic stroke
Carolei 1996 (Italy)
w12 308 cases, 591 controls Both sexes, women,
men (15-44)
Any, migraine with
and without aura
Ischaemic stroke, transient ischaemic
attack, ischaemic stroke+transient
ischaemic attack
Haapaniemi 1997 (Finland)
w15 506 cases, 345 controls Women, men (16-60) Any Ischaemic stroke
Schwartz 1998 (USA)
w23 373 cases, 1191 controls Women (18-44) Any Ischaemic stroke, haemorrhagic stroke
Chang 1999 (Europe)
w13 291 cases, 736 controls Women (20-44) Any, migraine with
and without aura
Ischaemic stroke, haemorrhagic stroke,
total stroke
Donaghy 2002 (Europe)
w14 86 cases, 214 controls Women (20-44) Migraine with
and without aura
Ischaemic stroke SubcohortfromChang1999
w13;withfocus
on interaction of frequency and recency of
association between migraine and
ischaemic stroke
Schwaag 2003 (Germany)
w22 160 cases, 160 controls Both sexes (<46) Any Ischaemic stroke+transient ischaemic
attack
MacClellan 2007 (USA)
w4 386 cases, 614 controls Women (15-49) Migraine with and without aura Ischaemic stroke “Probable migraine” investigated
Pezzini 2007 (Italy)
w5 333 cases, 187 controls Both sexes (<45) Migraine with and without aura Ischaemic stroke Only stratified analysis according to
cervical artery dissection
Cohort:
Sternfeld 1995 (USA)
w7 79 588 participants Women, men (any) Any Myocardial infarction Two cohorts distinguished because
ascertainment of migraine changed during
study period
Hall 2004 (UK)
w1 140 814 patients Both sexes (any) Any Ischaemic stroke, haemorrhagic stroke,
total stroke, myocardial infarction,
coronary heart disease, death due to
cardiovascular disease
Same database as in Nightingale 2004
18
and Becker 2007
w11
Velentgas 2004 (USA)
w8 260 822 participants Both sexes (any) Any Transient ischaemic attack, total stroke,
myocardial infarction, angina, death due
to cardiovascular disease
Kurth 2005 (USA)
w18 39 717 participants Women (≥45) Any, migraine with
and without aura
Ischaemic stroke, haemorrhagic stroke,
total stroke
Same cohort, but shorter follow-up as in
Kurth 2006
w3
Kurth 2006 (USA)
w3 27 840 participants Women (≥45) Any, migraine with
and without aura
Majorcardiovasculardisease,*ischaemic
stroke, myocardial infarction, angina,
coronary revascularisation procedure,
death due to cardiovascular disease
Ahmed 2006 (USA)
w9 873 participants Women (any) Any Admissiontohospitalforangina,coronary
revascularisationprocedure,deathdueto
cardiovascular disease
“Admission to hospital for angina”
investigated
Becker 2007 (UK)
w11 103 376 participants Both sexes, women,
men (≤80)
Any, migraine with
and without aura
Transient ischaemic attack, total stroke Same database as in Hall 2004
w1 and
Nightingale 2004
18
Kurth 2007 (USA)
w2 20 084 participants Men (40-84) Any Majorcardiovasculardisease,*ischaemic
stroke, myocardial infarction, angina,
coronary revascularisation procedure,
death due to cardiovascular disease
Liew 2007 (Australia)
w19 1732 participants Women, men (≥49) Any, migraine with
and without aura
Death due to coronary heart disease
Kurth 2008 (USA)
w17 27 519 participants Women (≥45) Migraine with and without aura Majorcardiovasculardisease,*ischaemic
stroke, myocardial infarction
Same cohort and follow-up as in Kurth
2006
w3; focus on interaction of vascular
risk on association between migraine and
cardiovascular disease
Cross sectional:
Rose 2004 (USA)
w21 12 409 participants Women, men (45-64) Migraine with and without aura Coronary heart disease, angina Cross sectional study, that presents
“verified coronary heart disease events
after headache onset,” heterogeneous
coronary heart disease outcome
(myocardial infarction, silent myocardial
infarction,CABG,PTCA,fatalcoronaryheart
disease)
Stang 2005 (USA)
w6 12 750 participants Both sexes (45-64) Migraine with and without aura Ischaemic stroke Cross sectional study, but presents results
for “incident ischaemic stroke” (verified
stroke events restricted to first stroke and
strokesoccurringafteronsetofheadaches)
CABG=coronary artery bypass grafting; PTCA=percutaneous transluminal coronary angioplasty.
*Combined end point—first of any of ischaemic stroke, myocardial infarction, or death due to cardiovascular disease.
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Study design, reference,
and age range Population
Oral contraceptive
users Smoking Migraine type
Relative risk (95% CI)
Any stroke Ischaemic stroke
Transient
ischaemic attack Haemorrhagic stroke
Case-control
Henrich 1989
w16:
15-65 Both sexes —— Any — 1.8 (0.9 to 3.6) ——
15-65 Both sexes —— Migraine with aura — 2.6 (1.1 to 6.6) ——
15-65 Both sexes —— Migraine without aura — 1.3 (0.5 to 3.6) ——
Tzourio 1993
w24:
18-80 Both sexes —— Any — 1.3 (0.8 to 2.3) ——
18-80 Women —— Any — 1.6 (0.7 to 3.5) ——
18-80 Men —— Any — 1.1 (0.5 to 2.2) ——
18-80 Both sexes —— Migraine with aura — 1.3 (0.5 to 3.8) ——
18-80 Both sexes —— Migraine without aura — 0.8 (0.4 to 1.5) ——
<45 Women —— Any — 4.9 (1.1 to 21.4) ——
<45 Women — Yes Any — 10.2 (1.1 to 93.3) ——
Tzourio 1995
w25:
18-44 Women —— Any — 3.5 (1.8 to 6.4) ——
18-44 Women —— Migraine with aura — 6.2 (2.1 to 18.0) ——
18-44 Women —— Migraine without aura — 3.0 (1.5 to 5.8) ——
18-44 Women Current — Any — 13.9 (5.5 to 35.1) ——
18-44 Women — Yes Any — 10.2 (3.5 to 29.9) ——
Carolei 1996
w12:
15-44 Both sexes —— Any — 1.3 (0.7 to 2.4) 2.5 (1.2 to 4.9) —
15-44 Both sexes —— Migraine with aura — 8.6 (1.0 to 75) 3.3 (0.6 to 20) —
15-44 Both sexes —— Migraine without aura — 1.0 (0.5 to 2.0) 2.3 (1.1 to 4.9) —
Haapaniemi 1997
w15:
16-60 Men —— Any — 2.12 (1.05 to 2.95) ——
Schwartz 1998
w23:
18-44 Women Current — Any — 2.08 (1.19 to 3.65) — 2.15 (0.85 to 5.45)
Chang 1999
w13:
20-44 Women —— Any 1.78 (1.14 to 2.77) 3.54 (1.30 to 9.61) — 1.10 (0.63 to 1.94)
20-44 Women —— Migraine with aura 1.62 (0.98 to 2.67) 3.81 (1.26 to 11.5) — 0.86 (0.44 to 1.67)
20-44 Women —— Migraine without aura 2.25 (1.10 to 4.63) 2.97 (0.66 to 13.5) — 1.84 (0.77 to 4.39)
20-44 Women Not current — Any — 2.27 (0.69 to 7.47) — 1.13 (0.60 to 2.12)
20-44 Women Current — Any — 16.9 (2.72 to 106) — 1.10 (0.40 to 2.97)
20-44 Women — No Any — 1.56 (0.41 to 5.85) — 0.75 (0.31 to 1.79)
20-44 Women — Yes Any — 7.39 (2.14 to 25.5) — 2.66 (1.29 to 5.49)
MacClellan 2007
w4:
15-49 Women —— Migraine with aura — 1.5 (1.1 to 2.0) ——
15-49 Women —— Migraine without aura — 1.0 (0.6 to 1.5) ——
15-49 Women — Yes Migraine with aura — 1.5 (1.1 to 2.3) ——
15-49 Women Current Yes Migraine with aura — 10.0 (1.4 to 73.7) ——
Cohort
Hall 2004
w1:
Any Both sexes —— Any 1.52 (1.29 to 1.78) 2.49 (1.62 to 3.83) — 1.34 (0.90 to 1.99)
Velentgas 2004
w8:
Any Both sexes —— Any 1.67 (1.31 to 2.13) — 2.24 (1.63 to 3.09) —
Kurth 2005
w18:
≥45 Women —— Any 1.23 (0.90 to 1.69) 1.36 (0.97 to 1.92)†— 0.78 (0.33 to 1.82)
Kurth 2006
w3:
≥45 Women —— Any — 1.22 (0.88 to 1.68) ——
≥45 Women —— Migraine with aura — 1.91 (1.17 to 3.10) ——
≥45 Women —— Migraine without aura — 1.27 (0.77 to 2.09) ——
Becker 2007
w11:
≤80 Both sexes —— Any 2.2 (1.7 to 2.9)†— 2.4 (1.8 to 3.3) —
Kurth 2007
w2:
40-84 Men —— Any — 1.12 (0.84 to 1.50) ——
Cross sectional
Stang 2005
w6:
45-64 Both sexes —— Migraine with aura — 2.07 (0.96 to 4.44) ——
45-64 Both sexes —— Migraine without aura — 0.86 (0.37 to 2.00) ——
*Only effect estimates pertaining to our a priori defined categories for analyses are listed.
†Effect estimates not used for our analyses as competing studies were available.
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(I
2=65%); less for case-control studies (I
2=42%) than
cohort studies (I
2=79%). Meta-regression showed that
study type (case-control v cohort) was not a significant
source of heterogeneity (P=0.3), and accounted for
only 6.8% of the variance across all studies. Further
analysis suggested an increased risk of ischaemic
stroke among women (pooled relative risk 2.08, 95%
confidence interval 1.13 to 3.84) but not among men
(1.37, 0.89 to 2.11). Meta-regression did not, however,
indicate that sex accounts for significant heterogeneity
across the studies (P=0.31). The risk for people with
migraine aged less than 45 (2.65, 1.41 to 4.97) was
higherthanfortheoverallgroup,whichwasmorepro-
nouncedamongwomen(3.65,2.21to6.04).Theriskof
ischaemic stroke seemed to be further increased
among smokers (9.03, 4.22 to 19.34) and women cur-
rently using oral contraceptives (7.02, 1.51 to 32.68).
Formal investigation using Begg’s test indicated no
publication bias (P=0.095), whereas Egger’s test sug-
gested some publication bias (P=0.045). The funnel
plot is presented in fig 3.
Eight studies investigated the association between
migraine and ischaemic stroke stratified by migraine
aura status.
w3 w4 w6 w12 w13 w16 w24 w25 Pooled analyses sug-
gestedasignificantlyincreasedriskofischaemicstroke
among people who had migraine with aura (2.16, 1.53
to 3.03) but not those who had migraine without aura
(1.23, 0.90 to 1.69; fig 4). This agrees with results from
meta-regression,whichindicatethatmigraineaurasta-
tus is a significant source of heterogeneity across stu-
dies (P=0.02) and that 42% of the variance between
studies is explained by this variable.
Three studies each investigated the association
between any migraine and transient ischaemic
attacks
w8 w11 w12 and haemorrhagic stroke.
w1 w13 w18 The
risk of transient ischaemic attacks seemed to be
increased more than twofold (2.34, 1.90 to 2.88), but
there was no association with haemorrhagic stroke
(1.18, 0.87 to 1.60).
Association between migraine and myocardial ischaemia
Eight studies (four cohorts from one paper
w7) investi-
gated the association between any migraine and myo-
cardial infarction.
w1-w3 w7 w8 Overall analyses (fig 5) and
analyses stratified by sex did not suggest an increased
risk. Although heterogeneity was moderate across the
studies(I
2=59%),itdidnotseemtobeaccountedforby
sex (meta-regression P=1.00). Publication bias was not
indicated (Begg’s test P=0.62; Egger’s test P=0.77).
Onlyonestudypresentedresultsstratifiedbymigraine
aura status.
w3 Migraine with aura (relative risk 2.08,
95%confidence interval1.30 to3.31)but not migraine
without aura seemed to be associated with a twofold
increased risk of myocardial infarction.
Three studies investigated the association between
migraine and angina.
w2 w3 w8 Among participants with
any migraine the risk of angina seemed to be slightly
but significantly increased (pooled relative risk 1.29,
95% confidence interval 1.12 to 1.47). Results from
single studies suggest that the risk is higher in women
than in men. The overall heterogeneity was low
(I
2=44%) and publication bias was not indicated
(Begg’s test P=0.12; Egger’s test P=0.36). Only one
study presented analyses stratified by migraine aura
status,
w3 which suggested a significantly increased risk
in people who had migraine with aura (relative risk
1.71, 95% confidence interval 1.16 to 2.53) but not
migraine without aura.
Table 3 |Cohort studies included for analyses investigating association between migraine and myocardial infarction, angina,
and death due to cardiovascular disease*
Study and age range Population Migraine type
Relative risk (95% CI)
Myocardial
infarction Angina
Death due
to cardiovascular disease
Sternfeld 1995
w7:
Any Women Any 0.7 (0.4 to 1.0) ——
Any Men Any 0.8 (0.5 to 1.2) ——
Any Women Any 1.4 (0.9 to 2.1) ——
Any Men Any 1.2 (0.7 to 1.9) ——
Hall 2004
w1:
Any Both sexes Any 1.15 (0.96 to 1.38) — 0.93 (0.76 to 1.13)
Velentgas 2004
w8:
Any Both sexes Any 0.96 (0.80 to 1.15) 1.33 (1.13 to 1.56) 0.60 (0.33 to 1.09)
Kurth 2006
w3:
≥45 Women Any 1.41 (1.03 to 1.91) 1.47 (1.17 to 1.86) 1.63 (1.07 to 2.50)
≥45 Women Migraine with aura 2.08 (1.30 to 3.31) 1.71 (1.16 to 2.53) 2.33 (1.21 to 4.51)
≥45 Women Migrainewithoutaura 1.22 (0.73 to 2.05) 1.12 (0.75 to 1.66) 1.06 (0.46 to 2.45)
Ahmed 2006
w9:
Any Women Any — 1.27 (0.93 to 1.75)† 1.16 (0.20 to 6.7)
Kurth 2007
w2:
40-84 Men Any 1.42 (1.15 to 1.77) 1.15 (0.99 to 1.33) 1.07 (0.80 to 1.43)
*Only effect estimates pertaining to our a priori defined categories for analyses are listed.
†Effect estimates not used for our analyses, as they failed to meet our a priori defined criteria for outcomes.
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cardiovascular disease
Five studies investigated the association between any
migraine and death dueto cardiovasculardisease.
w1-w3
w8 w9Theanalysisdidnotsuggestanoverallassociation
(pooledrelativerisk1.03,95%confidenceinterval0.79
to1.34;fig6).Thetwostudiesinvestigatingtheassocia-
tion amongwomen found an increased risk (1.60, 1.06
to 2.42), which was not the case in another study
among men. Heterogeneity was moderate across all
studies (I2=54%) and publication bias was not indi-
cated (Begg’s test P=1.0; Egger’s test P=0.9). The one
studythatinvestigatedauraspecificassociationsfound
an increased risk only among people who had
migraine with aura (relative risk 2.33, 95% confidence
interval 1.21 to 4.51) not migraine without aura.
Sensitivity analyses
The Galbraith plots for some analyses identified indi-
vidual studies as important sources of heterogeneity.
Table 4 |Association between migraine and cardiovascular events, heterogeneity, and publication bias
Migraine type and cardiovascular disease event
No of
studies
Relative risk
(95% CI)*
Heterogeneity Publicationbias(Pvalue)
Q
Degrees of
freedom P value I2 (%)
Begg’s
test
Egger’s
test
Any migraine type and ischaemic stroke:
All studies (case-control and cohort)
w1-w3 w12 w13 w15 w16 w24 w25 9 1.73 (1.31 to 2.29) 22.9 8 0.004 65 0.095 0.045
Case-control studies
w12 w13 w15 w16 w24 w25 6 1.96 (1.39 to 2.76) 8.7 5 0.12 42 0.35 0.34
Cohort studies
w1-w3 3 1.47 (0.95 to 2.27) 9.7 2 0.008 79 0.12 0.10
Women
w3 w13 w24 w25 4 2.08 (1.13 to 3.84) 11.0 3 0.01 73 0.50 0.22
Men
w2 w15 w24 3 1.37 (0.89 to 2.11) 4.6 2 0.1 57 0.6 0.72
Women and men <45 years
w12 w13 w24 w25 4 2.65 (1.41 to 4.97) 6.6 3 0.09 55 0.5 0.5
Women <45 years
w13 w24 w25 3 3.65 (2.21 to 6.04) 0.17 2 0.9 0 0.12 0.34
Women ≥45 years
w3 1 1.22 (0.88 to 1.68) —— — — — —
Women currently using oral contraceptives
w13 w23 w25 3 7.02 (1.51 to 32.68) 14.5 2 0.001 86 0.6 0.4
Women currently not using oral contraceptives
w13 1 2.27 (0.69 to 7.47) —— — — — —
Smokers
w13 w24 w25 3 9.03 (4.22 to 19.34) 0.2 2 0.9 0 0.6 0.96
Non-smokers
w13 1 1.56 (0.41 to 5.85) —— — — — —
Migraine with aura and ischaemic stroke:
All studies
w3 w4 w6 w12 w13 w16 w24 w25 8 2.16 (1.53 to 3.03) 11.5 7 0.12 39 0.026 0.02
Smokers
w4 1 1.5 (1.1 to 2.3) —— — — — —
Women currently using oral contraceptives
w4 1 Not given —— — — — —
Women currently using oral contraceptives and smoking
w4 1 10.0 (1.4 to 73.7) —— — — — —
Migraine without aura and ischaemic stroke
w3 w4 w6 w12 w13 w16 w24 w25 8 1.23 (0.90 to 1.69) 11.4 7 0.12 39 0.32 0.48
Any migraine type and transient ischaemic attack
w8 w11 w12 3 2.34 (1.90 to 2.88) 0.13 2 0.9 0 0.6 0.68
Any migraine type and haemorrhagic stroke
w1 w13 w18 3 1.18 (0.87 to 1.60) 1.4 2 0.5 0 0.12 0.002
Any migraine type and any stroke
w1 w8 w13 w18 4 1.53 (1.36 to 1.72) 2.8 3 0.43 0 1.0 0.98
Any migraine type and myocardial infarction:
All studies
w1-w3 w7 w8† 8 1.12 (0.95 to 1.32) 17.1 7 0.02 59 0.62 0.77
Women
w3 w7‡ 3 1.14 (0.75 to 1.73) 6.87 2 0.03 71 0.12 0.51
Men
w2 w7‡ 3 1.15 (0.81 to 1.64) 5.36 2 0.07 63 0.60 0.44
Migraine with aura and myocardial infarction
w3 1 2.08 (1.30 to 3.31) —— — — — —
Migraine without aura and myocardial infarction
w3 1 1.22 (0.73 to 2.05) —— — — — —
Any migraine type and angina:
All studies
w2 w3 w8 3 1.29 (1.12 to 1.47) 3.58 2 0.17 44 0.12 0.36
Women
w3 1 1.47 (1.17 to 1.86) —— — — — —
Men
w2 1 1.15 (0.99 to 1.33) —— — — — —
Migraine with aura and angina
w3 1 1.71 (1.16 to 2.53) —— — — — —
Migraine without aura and angina
w3 1 1.12 (0.75 to 1.66) —— — — — —
Any migraine type and death due to cardiovascular disease:
All studies
w1-w3 w8 w9 5 1.03 (0.79 to 1.34) 8.6 4 0.07 54 1.0 0.9
Women
w3 w9 2 1.60 (1.06 to 2.42) 0.14 1 0.7 0 0.32 —
Men
w2 1 1.07 (0.80 to 1.43) —— — — — —
Migraine with aura and death due to cardiovascular disease
w3 1 2.33 (1.21 to 4.51) —— — — — —
Migraine without aura and death due to cardiovascular disease
w3 1 1.06 (0.46 to 2.45) —— — — — —
*From random effects model.
†Four study cohorts from one paper.
‡Two study cohorts from one paper.
RESEARCH
BMJ | ONLINE FIRST | bmj.com page 7 of 11Sensitivity analyses were carried out after excluding
studies that did not fall within two standard deviations
ofthezscore.Formostofthe analysesevaluatinglinks
between migraine and stroke, the associations did not
change, albeit the effect estimates were lower. For
example, after excluding three studies,
w1 w2 w25 the
pooledrelativeriskforthe associationbetweenischae-
micstrokeandanymigrainewas1.54(95%confidence
interval1.18to2.00),formigrainewithaura(onestudy
excluded
w25)itwas1.80(1.41to2.30),andformigraine
without aura (one study excluded
w25) it was 1.06 (0.83
to 1.37). However, after excluding one study
w25 the
overall association between migraine and ischaemic
stroke among women did not reach statistical signifi-
cance (pooled relative risk 1.64, 0.94 to 2.86).
Although no significant overall association was
shown between any migraine and myocardial infarc-
tion in the sensitivity analysis (1.12, 0.96 to 1.30; two
studies excluded
w2 w7), the analyses stratified by sex
did: the pooled relative risk among women was 1.41
(95%confidenceinterval1.10to1.81)andamongmen
was 1.38 (1.14 to 1.69, one cohort from one study
excluded in each case
w7). In a further sensitivity analy-
sis the results between any migraine and death due to
cardiovasculardiseasewerevirtuallyunchanged(0.93,
0.81 to 1.10; one study excluded
w3).
DISCUSSION
The results of this meta-analysis indicate that people
with migraine are at an increased risk of ischaemic
stroke. This increased risk is only apparent in those
who have migraine with aura and not in those with
migraine without aura, the relative risk being double.
In addition, the results suggest an approximately two-
fold higher risk among women compared with men.
Factors that further increased the risk of ischaemic
stroke were age less than 45 years, smoking, and use
of oral contraceptives. Among people with migraine,
the risk of transient ischaemic attacks seemed to be
higher than that for ischaemic stroke. In contrast, we
did not find an association with haemorrhagic stroke.
We also did not find an association between any
migraine type and myocardial infarction or death due
to cardiovascular disease. Only one study investigated
the association between migraine with aura and these
events,which showeda twofoldincreasedrisk ofmyo-
cardial infarction and death due to cardiovascular dis-
ease.Theriskforanginawasincreasedbyabout30%in
the pooled analysis.
Limitations of the study
The following limitations need to be considered.
Firstly, migraine is biologically heterogeneous,
19 and
migrainewithorwithoutauraareextremesofadisease
continuum.
2021 Although the International Classifica-
tion of Headache Disordershas established criteria for
migraine and migraine aura status,
22 the clinical spec-
trum among patients is still wide and the classification
of migraine or migraine aura may not capture this het-
erogeneity.Secondly,methodstoobtainadiagnosisof
migraine differed between studies. Some studies used
the criteria of the International Classification of Head-
ache Disorders,
w5 w12 w13 w22 w24 w25 some used self admi-
nistered questionnaires,
w2-w4 w6 w19 w21 and others used
databases from health insurance data.
w1 w7 w8 w11 w23
Although the clinical diagnosis constitutes the gold
standard, the other methods are also valid. Large
scale population based studies using data from ques-
tionnaires have proved to be successful in reaching a
valid diagnosis for migraine,
23-25w3 and information in
health insurance databases is often based on medical
records or claims. Thirdly, some of the included stu-
dies did not differentiate between migraine aura sta-
tus,
w1 w2 w15 w23 which is an important source of
heterogeneity for the overall results. This is reflected
by the results of the analyses between migraine and
ischaemic stroke, indicating that migraine aura status
accounts for 42% of the heterogeneity across the stu-
dies. Fourthly, in some studies the distinction between
migraine with aura and migraine without aura relied
on a single question, potentially leading to misclassifi-
cation.
w3 w17 Fifthly, there is a suggestion that publica-
tionbiasmayactinthepooledanalysesforsomeofthe
associations investigated—for example, the P value
from Egger’s test for the overall analysis between
  Henrich 1989
w16
  Tzourio 1993w24
  Tzourio 1995
w25
  Carolei 1996w12
  Haapaniemi 1997
w15
  Chang 1999w13
  Hall 2004w1
  Kurth 2006
w3
  Kurth 2007
w2
Combined
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Fig 2 | Association between any migraine and ischaemic
stroke (all studies)
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Fig 3 | Funnel plot for studies investigating association
between any migraine and ischaemic stroke
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cant (P=0.045). In the funnelplot (fig 3) this may trans-
lateintothe“gap”seeninthelowerrighthandcorner,a
potential indication that the results from smaller stu-
dies showing no association might not have been pub-
lished. However, asymmetrical funnel plots are no
proof of publication bias as they may arise from other
underlying study characteristics. Unknown heteroge-
neity among the studies may account for that in part,
which remained low to moderate even within the var-
ious subgroups investigated (table 4). Sixthly, cardio-
vascular disease is a collective term including different
vascular events. Some of the studies provided results
only for combined outcomes such as ischaemic stroke
plus transient ischaemic attacks
w10 w20 w22 and coronary
heart disease (consisting of myocardial infarction,
silent myocardial infarction, coronary artery bypass
graft surgery, percutaneous transluminal coronary
angioplasty, fatal coronary heart disease)
w21 or used
specific outcomes such as “angina leading to hospitali-
zation”
w9 that could not be grouped with other studies
investigating any angina. We applied stringent criteria
for grouping the studies according to cardiovascular
events, but even stroke subtypes, myocardial infarc-
tion, or death due to cardiovascular disease may
involve diverse biological mechanisms. Thus, despite
identifying 25 studies, we were left with no more than
nine for our a priori defined categories; some of the 25
studies could not be grouped with the other studies.
w5
w10 w14 w17 w19-w22Wechosethisapproachoveroneusing
weighting to reduce heterogeneity and to reflect more
accurately the medical reality in clinical practice.
Seventhly,forouroverallanalysesweapriorigrouped
studies irrespective of study type (case-control and
cohort) and sex of participants. Indeed meta-regres-
sion supported these assumptions and did not identify
study type or sex as significant sources of variability
across studies between migraine and ischaemic stroke.
Eighthly, we pooled odds ratios from case-control stu-
dies and hazard ratios from cohort studies to obtain
pooled relative risk estimates. Given the lack of infor-
mation on incidence rates from case-control studies,
however, we could not determine the absolute risks
orriskdifferencesforthepooleddata.Fromindividual
cohort studies it is suggested that the absolute risks for
cardiovascular disease among people with migraine
are considerably low.
w3 w7 w8 Finally, we used only
extractable data from the identified papers and did
not contact authors to obtain additional information.
Only one study, however, had insufficient data,
14 and
theoutcomeinvestigatedwas“overallstroke,”thusthe
results of our major outcomes would not have been
altered.
Our results must be interpreted in view of the char-
acteristics of the individual studies and the diseases
investigated. Based on the vascular phenomena
described in migraine,
26 the association between
migraine and cardiovascular disease has been the
focus of attention for decades. While on the basis of
currentevidencetheconsensusseemstobethatneural
mechanisms are the main cause of migraine and that
vascular findings only constitute epiphenomena,
27
reports linking migraine with cardiovascular disease
have accumulated. Most studies have investigated the
association of migraine with ischaemic stroke and sup-
port a link between the two conditions, which is sub-
stantiated by a meta-analysis of data published until
2004.
6 This previous meta-analysis reported a twofold
increased risk of ischaemic stroke among people with
migraine, which was similar between migraine with
  Henrich 1989
w16
  Tzourio 1993
w24
  Tzourio 1995
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Fig 4 | Association between migraine with and without aura
and ischaemic stroke
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Fig 5 | Association between any migraine and myocardial
infarction
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people with migraine aged less than 45 years, and
clearly increased among women using oral contracep-
tives. Our overall results agree in part with this meta-
analysis, showing a 73% increased risk of ischaemic
stroke for people with migraine, which was increased
for smokers, women using oral contraceptives, and
younger people. In contrast with the previous meta-
analysis,however,ourresultssuggestthatanincreased
riskofischaemicstrokeisonlyapparentamongpeople
who have migraine with but not without aura. Several
reasonsmayaccountforthediscrepantfinding.Firstly,
three large population based studies have been pub-
lished since the first meta-analysis.
w1-w3 Secondly, the
previous meta-analysis
6 included competing studies
utilising data from the same underlying study
cohort.
w13 w14 Thirdly, the previous meta-analysis con-
sidered studies investigating both “ischaemic stroke”
and“ischaemicstrokeplustransientischaemicattacks”
as a combined end point.
w10 w20 w22 However, migraine
aura, epileptic conditions, and presyncopal conditions
may be misdiagnosed as transient ischaemic attacks,
falsely increasing the effect estimate.
28 This notion is
also supported by our data, showing a higher risk for
transient ischaemic attacks (pooled relative risk 2.34,
95% confidence interval 1.90 to 2.88) than for ischae-
mic stroke (1.73, 1.31 to 2.29). We excluded studies
that only reported results for a combined outcome of
ischaemic stroke and transient ischaemic attacks.
Publications over the past years have focused not
only on the association of migraine with ischaemic
stroke but also on the association of migraine with
other vascular events, including haemorrhagic stroke,
myocardialinfarction,angina,anddeathduetocardio-
vascular disease. Our pooled results do not suggest an
association between overall migraine and haemorrha-
gic stroke, myocardial infarction, or death due to
cardiovascular disease, whereas the risk of angina
seems to be increased by 30%. Individual studies
have reported a twofold increased risk of myocardial
infarction,angina,anddeathduetocardiovasculardis-
easeforpeoplewhohavemigrainewithaura,
w3butnot
for haemorrhagic stroke.
w18
Pooled analyses further indicate that the risk of
ischaemic stroke is significantly higher among
women than among men. In contrast, the lack of an
association between migraine and myocardial infarc-
tion did not differ between women and men. This
may indicate a differential pathophysiology between
migraine and ischaemic stroke and between migraine
and myocardial infarction, as well as sex specific
effects. Although the associations between migraine
and angina and between migraine and death due to
cardiovascular disease suggest a higher risk among
women than among men, studies were too few to
allow a reliable assessment. Certain conditions
among women, especially young women, seem to be
importantdeterminantsinincreasingtheriskofcardio-
vascular events, even in the absence of overt athero-
sclerotic disease. Sex hormones may be such
candidates; they have been associated with risk of
both migraine and cardiovascular events.
29 In addi-
tion,their“magnitudeofimpact”maybemuchgreater
onthecervical-cranialcirculationthanonthecoronary
circulation. This needs further investigation.
Implications for clinical practice
The mostconsistent evidence was the increased risk of
ischaemic stroke among people with migraine, which
seems to be driven by migraine with aura. In addition,
the risk seemed to be further magnified by being
younger (<45 years), being female, smoking, and
using oral contraceptives. Thus, in particular, young
women who have migraine with aura should be
strongly advised to stop smoking, and methods of
birth control other than oral contraceptives may be
considered. Some evidence shows that among
women who have migraine with aura the combination
of smoking and use of oral contraceptives leads to the
highest risk estimates for ischaemic stroke.
w4 Firm evi-
dence on the association of migraine and other ischae-
mic vascular events is lacking. Therefore patients with
migraine should be treated the same as any other
patient without migraine: they should be screened for
traditional cardiovascular risk factors, such as hyper-
tension,adverselipidprofile,andincreasedriskofcor-
onary heart disease and, if appropriate, these risk
factors should be modified.
Directions for future research
Additional research is needed to delineate in more
detail the association between migraine and cardio-
vascular disease. Future studies need to be adequately
powered, should use a strict diagnosis of migraine,
should include aura status, should present results for
clearly defined cardiovascular events such as ischae-
mic stroke and myocardial infarction (not just com-
bined end points), and should present results
stratified by important and biologically meaningful
modifying factors in addition to overall analyses.
Furthermore, studies need to control for risk factors
associated with cardiovascular disease. Finally, mar-
kers of migraine severity, including frequency of
attacks and frequency of aura should be considered in
the association between migraine and cardiovascular
disease.
  Hall 2004w1
  Velentgas 2004
w8
  Kurth 2006w3
  Ahmed 2006
w9
  Kurth 2007w2
Combined
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Fig 6 | Association between any migraine and death due to
cardiovascular disease
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WHAT IS ALREADY KNOWN ON THIS TOPIC
Migraine has been associated with an increased risk of ischaemic stroke
Ameta-analysisreportedatwofoldincreasedriskofischaemicstrokeamongpeoplewhohad
migraine both with and without aura
Subsequent large case-control and cohort studies investigated the association between
migraine and various vascular events, including stroke subtypes, myocardial infarction, and
death due to cardiovascular disease
WHAT THIS STUDY ADDS
In this meta-analysis the risk of ischaemic stroke was approximately doubled among people
with migraine, which was apparent for migraine with aura but not migraine without aura
The risk was further increased by being female, age less than 45 years, smoking, and oral
contraceptive use
There was no association between migraine and myocardial infarction or death due to
cardiovascular disease
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